Milton Markowitz

3.9k total citations · 1 hit paper
56 papers, 2.5k citations indexed

About

Milton Markowitz is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology. According to data from OpenAlex, Milton Markowitz has authored 56 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Public Health, Environmental and Occupational Health, 13 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Milton Markowitz's work include Streptococcal Infections and Treatments (45 papers), Inflammasome and immune disorders (13 papers) and Hematological disorders and diagnostics (9 papers). Milton Markowitz is often cited by papers focused on Streptococcal Infections and Treatments (45 papers), Inflammasome and immune disorders (13 papers) and Hematological disorders and diagnostics (9 papers). Milton Markowitz collaborates with scholars based in United States, Israel and South Korea. Milton Markowitz's co-authors include Angelo Taranta, Leon Gordis, Abraham M. Lilienfeld, Michael A. Gerber, Edward L. Kaplan, Gene H. Stollerman, Michael D. Freed, Alan L. Bisno, Patricia Ferrieri and Masato Takahashi and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Milton Markowitz

55 papers receiving 2.1k citations

Hit Papers

Rheumatic Fever 1972 2026 1990 2008 1972 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milton Markowitz United States 25 1.5k 743 622 383 240 56 2.5k
Angelo Taranta United States 25 1.4k 1.0× 611 0.8× 573 0.9× 538 1.4× 320 1.3× 51 2.9k
Elizabeth Cooney United States 28 760 0.5× 456 0.6× 970 1.6× 245 0.6× 118 0.5× 61 2.8k
Basil Varkey United States 24 465 0.3× 550 0.7× 669 1.1× 92 0.2× 136 0.6× 86 2.5k
Nigel Wilson New Zealand 29 1.6k 1.1× 922 1.2× 1.3k 2.0× 283 0.7× 833 3.5× 111 2.9k
Enitan D. Carrol United Kingdom 30 514 0.4× 506 0.7× 1.5k 2.3× 202 0.5× 112 0.5× 125 2.7k
Sandra Melnick United States 31 546 0.4× 1.2k 1.6× 2.1k 3.3× 130 0.3× 92 0.4× 53 5.2k
Olivier Irion Switzerland 32 1.1k 0.8× 332 0.4× 413 0.7× 264 0.7× 177 0.7× 114 3.5k
Susan M. Cox United States 30 1.0k 0.7× 221 0.3× 1.1k 1.8× 71 0.2× 306 1.3× 100 2.8k
Scott Kellerman United States 24 294 0.2× 1.1k 1.4× 1.0k 1.7× 153 0.4× 232 1.0× 55 2.8k
Denise L. Jacobson United States 38 487 0.3× 2.3k 3.1× 1.1k 1.7× 233 0.6× 136 0.6× 96 5.2k

Countries citing papers authored by Milton Markowitz

Since Specialization
Citations

This map shows the geographic impact of Milton Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milton Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milton Markowitz more than expected).

Fields of papers citing papers by Milton Markowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milton Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milton Markowitz. The network helps show where Milton Markowitz may publish in the future.

Co-authorship network of co-authors of Milton Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Milton Markowitz. A scholar is included among the top collaborators of Milton Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milton Markowitz. Milton Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svendsen, Kenneth H., et al.. (1998). Community Advisory Boards: Their Role in AIDS Clinical Trials. Health & Social Work. 23(4). 290–297. 58 indexed citations
2.
Markowitz, Milton & Hung‐Chi Lue. (1996). Allergic Reactions in Rheumatic Fever Patients on Long-term Benzathine Penicillin G: The Role of Skin Testing for Penicillin Allergy. PEDIATRICS. 97(6). 981–983. 27 indexed citations
3.
Markowitz, Milton. (1994). Changing epidemiology of group A streptococcal infections. PubMed. 13(6). 557–560. 28 indexed citations
4.
Dajani, Adnan S., Elía M. Ayoub, Fredrick Z. Bierman, et al.. (1993). Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992: Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young, American Heart Association. Circulation. 87(1). 302–307. 285 indexed citations
5.
Markowitz, Milton, Michael A. Gerber, & Edward L. Kaplan. (1993). Treatment of streptococcal pharyngotonsillitis: Reports of penicillin's demise are premature. The Journal of Pediatrics. 123(5). 679–685. 78 indexed citations
7.
Markowitz, Milton, Edward L. Kaplan, R Cuttica, et al.. (1991). Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever.. The Lancet. 337(8753). 1308–1310. 96 indexed citations
8.
Johnstone, David W., et al.. (1991). Gastric duplication cyst communicating with the pancreatic duct: a rare cause of recurrent abdominal pain.. PubMed. 109(1). 97–100. 17 indexed citations
9.
Markowitz, Milton. (1991). Streptococcal disease in developing countries. The Pediatric Infectious Disease Journal. 10(Supplement). S11–14. 18 indexed citations
10.
Markowitz, Milton & Edward L. Kaplan. (1989). Reappearance of Rheumatic Fever. Advances in Pediatrics. 36(1). 39–65. 15 indexed citations
11.
Kaplan, Edward L. & Milton Markowitz. (1988). The fall and rise of rheumatic fever in the United States: a commentary. International Journal of Cardiology. 21(1). 3–10. 30 indexed citations
12.
Markowitz, Milton. (1985). The decline of rheumatic fever: Role of medical intervention. The Journal of Pediatrics. 106(4). 545–550. 59 indexed citations
13.
Markowitz, Milton. (1981). Observations on the epidemiology and preventability of rheumatic fever in developing countries.. PubMed. 4(4). 240–51. 20 indexed citations
14.
Gordis, Leon & Milton Markowitz. (1971). Prevention of Rheumatic Fever Revisited. Pediatric Clinics of North America. 18(4). 1243–1253. 2 indexed citations
15.
Rosenstein, Beryl J., et al.. (1968). Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. The Journal of Pediatrics. 73(4). 513–520. 51 indexed citations
16.
Markowitz, Milton, et al.. (1967). Persistence of group A streptococci as related to penicillinase-producing staphylococci: Comparison of penicillin V potassium and sodium nafcillin. The Journal of Pediatrics. 71(1). 132–137. 21 indexed citations
17.
Doyle, Eugenie F., et al.. (1967). The risk of bacterial endocarditis during antirheumatic prophylaxis.. PubMed. 201(11). 807–12. 34 indexed citations
18.
Markowitz, Milton, et al.. (1965). THE BACTERIOLOGIC FINDINGS, STREPTOCOCCAL IMMUNE RESPONSE, AND RENAL COMPLICATIONS IN CHILDREN AND IMPETIGO.. PubMed. 35. 393–404. 44 indexed citations
19.
Markowitz, Milton. (1963). STUDIES ON TYPE-SPECIFIC STREPTOCOCCAL ANTIBODIES AS INDICATORS OF PREVIOUS STREPTOCOCCAL INFECTIONS IN RHEUMATIC AND NONRHEUMATIC CHILDREN*. Journal of Clinical Investigation. 42(3). 409–416. 3 indexed citations
20.
Markowitz, Milton. (1962). Treatment of Acute Rheumatic Fever. Archives of Pediatrics and Adolescent Medicine. 104(3). 313–313. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026